ClinConnect ClinConnect Logo
Search / Trial NCT06014710

Modelling of Pharyngeal Laryngeal Effectiveness

Launched by UNIVERSITY HOSPITAL, TOULOUSE · Aug 22, 2023

Trial Information

Current as of November 14, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how well our throat and voice box work during swallowing, particularly for those with swallowing disorders. The researchers will use five non-invasive sensors (like a microphone and other simple devices) to gather information about swallowing, airway protection, and voice production. They aim to find reliable indicators that can help diagnose swallowing problems and assess their severity, which could lead to better treatment options.

To participate, patients must have a swallowing disorder and be able to follow up over the phone for six months. Healthy volunteers are also needed, but they must not have any swallowing difficulties. Throughout the study, participants can expect to undergo tests that monitor their swallowing and airway function, all while ensuring their comfort and safety. This research is important as it could help develop new, easier ways to diagnose and monitor swallowing disorders without invasive procedures.

Gender

ALL

Eligibility criteria

  • Inclusion criteria for patients with swallowing disorders :
  • Indication to perform a swallowing test (suspected or proven swallowing disorder or presence of a complication)
  • Able to follow up by phone for 6 months or have a caregiver who can answer for them
  • Affiliated subject or beneficiary of the social security system
  • Consent to participate obtained in writing and signed by the subject or, if applicable, the next of kin/support person
  • Inclusion criteria for healthy volunteers :
  • No swallowing disorder or discomfort (DHI score\<8)
  • Affiliated subject or beneficiary of the social security system
  • Signed Consent to Participate
  • Non-inclusion criteria for patients with swallowing disorders :
  • Skin lesion(s) at the neck
  • Tracheotomy or tracheostomy (laryngectomy)
  • Nasogastric probe
  • Iodine allergy
  • Asthma
  • Refusal or any pathology incompatible with passing one of the two reference exams or the sensors used
  • Any serious pathology (severe health or behavioral disorders) where, according to the investigator, this could expose participants to additional risks
  • Legal protection (guardianship, curators, safeguarding of justice)
  • Pregnant and lactating women
  • Non-inclusion criteria for healthy volunteers :
  • Medical history may result in chronic (history of oral-rhino-laryngeal cancer or neurological disease) or temporary (upper respiratory tract infections) swallowing impairment
  • Presence of swallowing disorder or discomfort (Deglutition Handicap Index score superior or equal to 8)
  • Skin lesion(s) at the neck
  • Tracheotomy or tracheostomy (laryngectomy)
  • Nasogastric probe
  • Iodine allergy
  • Asthma
  • Refusal or any pathology incompatible with passing one of the two reference exams or the sensors used
  • Any serious pathology (severe health or behavioral disorders) where, according to the investigator, this could expose participants to additional risks
  • Legal protection (guardianship, curators, safeguarding of justice)
  • Pregnant and lactating women

About University Hospital, Toulouse

The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.

Locations

Bordeaux, France

Tours, France

Toulouse, France

Rouen, France

Bordeaux, France

Patients applied

0 patients applied

Trial Officials

Virginie WOISARD, MD

Principal Investigator

University Hospital of Toulouse

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported